BAE Systems appoints Jane Griffiths to its Board as Non-Executive Director

– UK, London –  BAE Systems Plc (LON: BA) today announced the appointment of Jane Griffiths as a non-executive director of the Company with effect from 1 April 2020.

“I am delighted that Jane Griffiths has joined the BAE Systems Board. She has an impressive record of leading research-led, high technology businesses and brings a wealth of international corporate experience to the Board. Her advocacy and support for women business leaders is particularly noteworthy and relevant in helping us make further progress against our own diversity and inclusion objectives.” said Sir Roger Carr, Chairman.

The Board is pleased to confirm that Nick Rose has agreed to extend his term of appointment as a Non-Executive Director of the Company for up to one further year in order to support the Company through a challenging period associated with the Coronavirus crisis. His knowledge of the Company accumulated over the last ten years as a Board member, and his past roles as Chair of the Audit Committee and Senior Independent Director, will be invaluable in navigating the Company through these uncharted waters.

As previously announced, Tom Arseneault and Brad Greve also joined the Board on 1 April 2020; Tom has succeeded Jerry DeMuro as President & CEO of BAE Systems, Inc., and Brad has succeeded Peter Lynas as Group Finance Director.

About Jane Griffiths

Until retiring in December 2019, Jane Griffith enjoyed a long career with Johnson & Johnson, during which she held executive roles in clinical research, international and strategic marketing, product management and operational management. In her last role before retirement, Jane was Global Head of Actelion, where she led the integration of the Swiss biotech business following its acquisition by Johnson & Johnson. Prior to that, she had been Company Group Chair of Janssen EMEA, the group’s research-based pharmaceutical arm. During her time with Johnson & Johnson, she led its Corporate Citizen Trust in EMEA and sponsored its Women’s Leadership Initiative. She was also a sponsor of Janssen’s Global Pharmaceuticals Sustainability Council.

Jane is a past chair of the Executive Committee of the European Federation of Pharmaceutical Industries and Associations, past Chairwoman of the PhRMA Europe Committee and former member of the Corporate Advisory Board of the UK Government-backed ‘Your Life’ campaign, aimed at encouraging more people to study STEM subjects.

She is currently a non-executive director of Johnson Matthey Plc and a member of the board of directors of TB Alliance, a not-for-profit organisation dedicated to the discovery, development and delivery of better, faster-acting and affordable tuberculosis drugs that are available to those who need them.

For more information: https://www.baesystems.com

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.